Log in to save to my catalogue

Gene therapy using haematopoietic stem and progenitor cells

Gene therapy using haematopoietic stem and progenitor cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2483406445

Gene therapy using haematopoietic stem and progenitor cells

About this item

Full title

Gene therapy using haematopoietic stem and progenitor cells

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Genetics, 2021-04, Vol.22 (4), p.216-234

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Haematopoietic stem and progenitor cell (HSPC) gene therapy has emerged as an effective treatment modality for monogenic disorders of the blood system such as primary immunodeficiencies and β-thalassaemia. Medicinal products based on autologous HSPCs corrected using lentiviral and gammaretroviral vectors have now been approved for clinical use, and...

Alternative Titles

Full title

Gene therapy using haematopoietic stem and progenitor cells

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2483406445

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2483406445

Other Identifiers

ISSN

1471-0056

E-ISSN

1471-0064

DOI

10.1038/s41576-020-00298-5

How to access this item